药品注册申请号:009402
申请类型:NDA (新药申请)
申请人:ENDO OPERATIONS
申请人全名:ENDO OPERATIONS LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
002 DELESTROGEN ESTRADIOL VALERATE INJECTABLE;INJECTION 10MG/ML Yes Yes AO 1954/07/15 Approved Prior to Jan 1, 1982 Prescription
003 DELESTROGEN ESTRADIOL VALERATE INJECTABLE;INJECTION 40MG/ML Yes No AO Approved Prior to Jan 1, 1982 Discontinued
004 DELESTROGEN ESTRADIOL VALERATE INJECTABLE;INJECTION 20MG/ML Yes Yes AO Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/02/15 SUPPL-63(补充) Approval Labeling STANDARD
2022/02/16 SUPPL-60(补充) Approval Labeling STANDARD
2017/11/01 SUPPL-52(补充) Approval Labeling STANDARD
2016/03/10 SUPPL-49(补充) Approval Manufacturing (CMC)
2015/10/20 SUPPL-47(补充) Approval Manufacturing (CMC)
2015/08/11 SUPPL-46(补充) Approval Manufacturing (CMC)
2007/10/11 SUPPL-41(补充) Approval Manufacturing (CMC) N/A
2004/07/26 SUPPL-40(补充) Approval Labeling STANDARD
2003/12/12 SUPPL-39(补充) Approval Labeling STANDARD
2003/12/12 SUPPL-37(补充) Approval Labeling STANDARD
2002/07/17 SUPPL-38(补充) Approval Manufacturing (CMC)
1998/06/17 SUPPL-36(补充) Approval Labeling STANDARD
1990/01/12 SUPPL-35(补充) Approval Labeling
1989/05/05 SUPPL-34(补充) Approval Manufacturing (CMC)
1989/03/02 SUPPL-33(补充) Approval Labeling
1989/03/02 SUPPL-29(补充) Approval Labeling
1987/12/28 SUPPL-31(补充) Approval Labeling
1987/09/11 SUPPL-30(补充) Approval Manufacturing (CMC)
1986/05/05 SUPPL-27(补充) Approval Manufacturing (CMC)
1985/07/31 SUPPL-22(补充) Approval Manufacturing (CMC)
1985/01/15 SUPPL-26(补充) Approval Labeling
1984/11/26 SUPPL-25(补充) Approval Labeling
1984/11/16 SUPPL-24(补充) Approval Labeling
1984/06/01 SUPPL-23(补充) Approval Manufacturing (CMC)
1984/03/19 SUPPL-21(补充) Approval Labeling
1983/07/18 SUPPL-20(补充) Approval Manufacturing (CMC)
1982/09/07 SUPPL-19(补充) Approval Manufacturing (CMC)
1954/07/15 ORIG-1(原始申请) Approval UNKNOWN
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:ESTRADIOL VALERATE 剂型/给药途径:INJECTABLE;INJECTION 规格:10MG/ML 治疗等效代码:AO
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
009402 002 NDA DELESTROGEN ESTRADIOL VALERATE INJECTABLE;INJECTION 10MG/ML Prescription Yes Yes AO Approved Prior to Jan 1, 1982 ENDO OPERATIONS
203723 001 ANDA ESTRADIOL VALERATE ESTRADIOL VALERATE INJECTABLE;INJECTION 10MG/ML Prescription No No AO 2020/04/21 HIKMA
216656 001 ANDA ESTRADIOL VALERATE ESTRADIOL VALERATE INJECTABLE;INJECTION 10MG/ML Prescription No No AO 2023/04/28 XIROMED
活性成分:ESTRADIOL VALERATE 剂型/给药途径:INJECTABLE;INJECTION 规格:40MG/ML 治疗等效代码:AO
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
009402 003 NDA DELESTROGEN ESTRADIOL VALERATE INJECTABLE;INJECTION 40MG/ML Discontinued Yes No AO Approved Prior to Jan 1, 1982 ENDO OPERATIONS
090920 002 ANDA ESTRADIOL VALERATE ESTRADIOL VALERATE INJECTABLE;INJECTION 40MG/ML Prescription No No AO 2010/01/19 AM REGENT
203723 003 ANDA ESTRADIOL VALERATE ESTRADIOL VALERATE INJECTABLE;INJECTION 40MG/ML Prescription No No AO 2020/04/21 HIKMA
216656 003 ANDA ESTRADIOL VALERATE ESTRADIOL VALERATE INJECTABLE;INJECTION 40MG/ML Prescription No Yes AO 2023/04/28 XIROMED
活性成分:ESTRADIOL VALERATE 剂型/给药途径:INJECTABLE;INJECTION 规格:20MG/ML 治疗等效代码:AO
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
009402 004 NDA DELESTROGEN ESTRADIOL VALERATE INJECTABLE;INJECTION 20MG/ML Prescription Yes Yes AO Approved Prior to Jan 1, 1982 ENDO OPERATIONS
090920 001 ANDA ESTRADIOL VALERATE ESTRADIOL VALERATE INJECTABLE;INJECTION 20MG/ML Prescription No No AO 2010/01/19 AM REGENT
203723 002 ANDA ESTRADIOL VALERATE ESTRADIOL VALERATE INJECTABLE;INJECTION 20MG/ML Prescription No No AO 2020/04/21 HIKMA
216656 002 ANDA ESTRADIOL VALERATE ESTRADIOL VALERATE INJECTABLE;INJECTION 20MG/ML Prescription No No AO 2023/04/28 XIROMED
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database